MedTrace Logo

Effect of AI-Assisted Discharge Education on Parents of Children With Bronchitis/Bronchiolitis

NCT07774494 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2026-08-20

No results posted yet for this study

Summary

This randomized controlled trial aims to evaluate the effects of artificial intelligence-assisted discharge education on mothers of children hospitalized with bronchitis/bronchiolitis. A total of 162 mothers will be randomly assigned to one of three groups: AI-assisted written discharge education, AI-assisted video discharge education, or routine discharge education. The primary outcome will be mothers' knowledge of home care after discharge. Secondary outcomes will include anxiety, readiness for hospital discharge, and satisfaction with discharge education. The study hypothesizes that AI-assisted written and video discharge education will improve mothers' knowledge and readiness for discharge, reduce anxiety, and increase satisfaction compared with routine discharge education.

Conditions

Interventions

BEHAVIORAL

AI-Assisted Written Discharge Education

A written discharge education booklet developed with support from ChatGPT based on standard discharge content and expert review.

BEHAVIORAL

AI-Assisted Video Discharge Education

A video discharge education intervention developed with support from Gemini Notebook and designed to cover the same learning objectives as the written material.

BEHAVIORAL

Routine Discharge Education

Standard discharge education routinely provided by the institution.

Sponsors & Collaborators

  • Osmaniye Korkut Ata University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-10-15
Primary Completion
2027-06-15
Completion
2027-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07774494 on ClinicalTrials.gov